| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06 |
| filingDate |
1993-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9b729fdb4824eb154a257acf9f3e7eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ecfdad38afd800c2c8769c488be5b0 |
| publicationDate |
1993-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9319047-A1 |
| titleOfInvention |
Tetrahidropyridinyl (3/4) substitued oximes having sigma receptor affinity and their use in the treatment of central nervous system conditions |
| abstract |
Pharmaceutically useful compounds in the treatment of depression, psychoses, and inflammatory diseases having structure (I). |
| priorityDate |
1992-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |